V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 170003152 | 170004221 | 1.55 | 74.9 | null | 2017-01-04 | 2017-01-04 | null | null | null | VENETOCLAX | 101417079 |
| 170003156 | 170004222 | 1.75 | 67.1 | Palliative (P) | 2020-10-11 | 2021-02-05 | CNS Medullo HR Cis/Vinc/Cyclo + PBSCR | 02 | N | CISPLATIN + VINORELBINE | 100901512 |
| 170003341 | 170004225 | null | null | null | 2019-02-08 | 2019-02-10 | null | 01 | null | PERTUZUMAB + TRASTUZUMAB | 100028016 |
| 170003460 | 170004228 | 1.73 | 66.4 | null | null | 2020-10-12 | null | 02 | null | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101256092 |
| 170003906 | 170004234 | 1.74 | 54.7 | null | null | 2019-01-17 | null | 02 | null | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101859372 |
| 170004070 | 170004238 | null | null | null | 2021-05-26 | 2021-06-01 | null | null | null | FLUOROURACIL + IRINOTECAN | 101394476 |
| 170004411 | 170004246 | null | 70.1 | null | null | 2019-11-18 | null | null | null | TRIAL UNSPECIFIED | 101341676 |
| 170004531 | 170004248 | null | 54.7 | null | null | 2017-12-05 | null | null | null | LENALIDOMIDE | 100353854 |
| 170004660 | 170004249 | 1.71 | null | 03 | null | 2021-01-02 | null | 02 | N | DURVALUMAB | 100706309 |
| 170004702 | 170004250 | 1.51 | 67 | Disease modification (D) | 2021-11-09 | 2021-11-21 | MELPHALAN | 02 | null | DARATUMUMAB | 100237674 |
| 170004723 | 170004251 | null | null | null | 2020-02-13 | 2020-02-21 | Rituximab | null | null | ALECTINIB | 100539150 |
| 170004997 | 170004253 | null | null | Palliative (P) | 2022-05-19 | 2022-05-20 | null | 02 | N | ATEZOLIZUMAB | 101419621 |
| 170005129 | 170004257 | null | null | null | null | 2022-04-26 | null | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100139231 |
| 170005187 | 170004258 | null | 91 | null | null | 2018-12-15 | FLUDARABINE | 01 | null | PEMBROLIZUMAB | 101378852 |
| 170005324 | 170004261 | 1.58 | 61.3 | null | 2019-09-22 | 2019-10-20 | Trastuzumab Subcutaneous | null | null | CYCLOPHOSPHAMIDE + POMALIDOMIDE | 100113016 |
| 170005327 | 170004262 | 1.88 | 64.8 | null | 2019-09-03 | 2020-06-25 | null | null | null | CYCLOPHOSPHAMIDE | 101480706 |
| 170005341 | 170004263 | 1.6 | 59.9 | Curative (C) | 2019-09-19 | 2019-09-24 | null | 02 | N | CISPLATIN + PEMETREXED | 101394809 |
| 170005363 | 170004264 | 1.83 | null | null | null | 2016-06-14 | Bevacizumab | N | null | LENALIDOMIDE | 101726466 |
| 170005501 | 170004265 | null | null | null | null | 2020-10-26 | IGEV | null | null | OSIMERTINIB | 101442807 |
| 170005691 | 170004267 | 1.65 | 58.03 | Neo-adjuvant (N) | null | 2018-09-01 | null | 02 | N | CAPECITABINE | 101305232 |
| 170005764 | 170004271 | null | null | Palliative (P) | null | 2016-07-18 | null | 02 | N | ATEZOLIZUMAB + CARBOPLATIN + ETOPOSIDE | 100996594 |
| 170005790 | 170004272 | null | null | null | null | 2021-07-25 | GemCarbo Days 1+8 | null | null | BORTEZOMIB | 100564660 |
| 170006190 | 170004275 | null | null | Adjuvant (A) | null | 2017-10-21 | null | 02 | N | RITUXIMAB | 100442481 |
| 170006253 | 170004277 | null | null | null | 2016-11-09 | 2016-11-30 | Carboplatin AUC 2 - 5 | null | null | ERIBULIN | 101231136 |
| 170006304 | 170004279 | null | null | 03 | null | 2019-06-15 | DARATUMUMAB | 02 | null | IFOSFAMIDE + GEMCITABINE + VINORELBINE | 101756721 |
| 170006817 | 170004283 | 1.64 | 68.8 | null | null | 2021-06-16 | null | 99 | null | IBRUTINIB | 100301214 |
| 170006847 | 170004284 | 1.53 | 92.1 | null | null | 2015-03-17 | null | 02 | null | PEMBROLIZUMAB | 100294084 |
| 170007139 | 170004292 | null | null | null | 2022-02-03 | 2022-02-03 | null | null | null | CAPECITABINE | 100608511 |
| 170007384 | 170004298 | null | null | null | 2020-07-23 | 2020-07-23 | Bortezomib + MELPHALAN | null | null | CAPECITABINE | 101170491 |
| 170007417 | 170004299 | 1.76 | 61.2 | null | 2019-05-26 | 2019-06-18 | null | null | null | TRIAL UNSPECIFIED | 101004229 |
| 170007463 | 170004300 | null | null | 03 | null | 2020-05-25 | null | 01 | N | NAB-PACLITAXEL | 100638243 |
| 170008038 | 170004309 | 1.52 | null | null | 2020-10-15 | 2021-10-14 | Docetaxel | null | null | IMATINIB | 100420209 |
| 170008090 | 170004310 | 1.57 | 76 | null | null | 2018-03-20 | null | 99 | null | ABVD | 101193916 |
| 170008101 | 170004312 | null | 88 | null | null | 2019-01-16 | null | null | null | DOXORUBICIN + IFOSFAMIDE | 101263387 |
| 170008217 | 170004314 | null | 97.8 | Palliative (P) | 2021-02-14 | 2021-02-27 | null | 02 | N | LOMUSTINE | 101566353 |
| 170008236 | 170004315 | null | null | null | null | 2020-04-07 | null | null | null | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 100651403 |
| 170008297 | 170004319 | 1.86 | null | null | null | 2020-10-21 | Durvalumab | null | null | TRIAL UNSPECIFIED | 101007569 |
| 170008307 | 170004320 | 0 | 65.7 | null | null | 2019-08-13 | null | null | null | HYDROXYCARBAMIDE | 100887444 |
| 170008559 | 170004323 | null | null | Palliative (P) | null | 2018-12-18 | null | 02 | N | BORTEZOMIB + THALIDOMIDE | 100161387 |
| 170008562 | 170004324 | 1.78 | 25.5 | null | null | 2021-04-19 | Pertuzumab + Trastuzumab IV | 02 | null | BEVACIZUMAB | 101770425 |
| 170008622 | 170004326 | null | null | null | null | 2019-05-16 | null | 02 | null | MELPHALAN | 101510753 |
| 170008679 | 170004327 | null | null | 03 | null | 2019-09-07 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | N | CARBOPLATIN + NAB-PACLITAXEL | 100221584 |
| 170008860 | 170004329 | null | null | null | 2020-07-18 | 2020-07-18 | Epirubicin | null | null | CETUXIMAB + CISPLATIN + FLUOROURACIL | 101678149 |
| 170009317 | 170004336 | null | null | null | null | 2019-05-13 | null | null | null | ENZALUTAMIDE | 100971329 |
| 170009366 | 170004337 | null | 87.3 | null | 2018-01-18 | 2018-01-23 | null | 02 | null | LENALIDOMIDE | 100865888 |
| 170009381 | 170004338 | null | null | Palliative (P) | null | 2022-04-01 | FLUDARABINE | 02 | N | IBRUTINIB | 100408574 |
| 170009610 | 170004342 | 1.69 | 94.1 | null | null | 2021-01-10 | null | null | null | LETROZOLE + PALBOCICLIB | 101006225 |
| 170009659 | 170004343 | null | 61.7 | Palliative (P) | 2019-08-29 | 2019-09-23 | Bevacizumab | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101348114 |
| 170009744 | 170004345 | null | 48.5 | null | null | 2021-05-19 | null | null | null | MELPHALAN | 100692840 |
| 170010082 | 170004347 | null | 50.6 | null | null | 2021-02-19 | Trial Unspecified | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100841801 |